Información del artículo
El Texto completo está disponible en PDF
Biblografía
[1.]
Wilson SAK.
Progressive lenticular degeneration: a familial nervous disease associated with cirrhosis of the liver.
Brain, 34 (1912), pp. 295-509
[2.]
M. Frydman.
Genetics aspects of Wilson's disease.
J Gastroenterol Hepatol, 5 (1990), pp. 483-490
[3.]
R.E. Schoen, I. Sternlieb.
Clinical aspects of Wilson's disease.
Am J Gastroenterol, 85 (1990), pp. 1453-1457
[4.]
P.C. Bull, G.R. Thomas, J.M. Rommens, J.R. Forbes, D.W. Cox.
The Wilson disease gene is a putative copper transporting P-type ATPase similar to Menkes gene.
Nat Genet, 5 (1993), pp. 327-337
[5.]
K. Petrukhin, S.G. Fischer, M. Pirasdtu, R.E. Tanzi, I. Chernov, M. Devoto, et al.
Mapping cloning and genetic characterization of the region containing the Wilson disease gene.
Nat Genet, 5 (1993), pp. 338-343
[6.]
R.E. Tanzi, K. Petrukhin, I. Chernov, J.L. Pellequer, W. Wasco, B. Rose, et al.
The Wilson disease gene is a copper transporting ATPase with homology to the Menkes disease gene.
Nat Genet, 5 (1993), pp. 344-350
[7.]
T. Maier-Dobersberger, P. Fenenci, C. Polli, P. Balac, H.P. Dienes, K. Kaserer, et al.
Detection of the His 1069Glu mutation in Wilson disease by rapid polymerasa chain reaction.
Ann Intern Med, 127 (1997), pp. 21-26
[8.]
A. Czlonkowska, M. Rodo, J. Gajda, H.K. Ploos van Amstel, J. Juyn, R.H. Houwen.
Very high frequency of the His 1069Glu mutation in Polish Wilson disease patients.
J Neurol, 244 (1997), pp. 591-599
[9.]
G. Loudianos, V. Dessi, M. Lovicu, A. Angius, A. Figus, F. Lilliu, et al.
Molecular characterization of Wilson disease in the Sardinian population –evidence of a founder effect.
Hum Mutat, 14 (1999), pp. 294-303
[10.]
A.B. Shah, I. Chermov, H.T. Zhang, B.M. Ross, K. Das, S. Lutsenko, et al.
Identification and analysis of mutations in the Wilson disease gene (ATP7B): population frequencies, genotype-fenotype correlation, and functional analysis.
Am J Hum Genet, 61 (1997), pp. 317-328
[11.]
C.D. Vulpe, S. Packman.
Cellular copper transport.
Annu Rev Nutr, 15 (1995), pp. 293-322
[12.]
J.L. Gollan, T.J. Gollan.
Wilson disease in 1998: genetic, diagnostic and therapeutics aspects.
J Hepatol, 28 (1998), pp. 28-36
[13.]
B. Zhou, J. Gitscher.
hCTR1: a human gene for copper uptake identified by complementation in yeast.
Proc Natl Acad Sci USA, 94 (1997), pp. 7481-7486
[14.]
J.H. Freedman, M.R. Ciriolo, J. Peisach.
The role of glutathione in copper metabolism toxicity.
J Biol Chem, 264 (1989), pp. 5598-5605
[15.]
M.L. Schilsky, R.R. Blank, M.J. Czaja, M.A. Zern, I.H. Scheinberg, I.H. Stockert, et al.
Hepatocellular copper toxicity and its attenuation by zinc.
J Clin Invest, 84 (1989), pp. 1562-1568
[16.]
L.W. Klomp, S.J. Liu, D.S. Yuan, R.D. Klausner, V.C. Culotta, J.D. Gitlin.
Identification an functional expression of HAH1, a novel human gene involved in copper homeostasis.
J Biol Chem, 272 (1997), pp. 9332-9336
[17.]
K. Tereda, Y. Kawarda, N. Muira.
Copper incorporation into ceruloplasmin in rat livers.
Biochim Biophys Acta, 1270 (1995), pp. 58-63
[18.]
Z.L. Harris, Y. Takahashi, H. Miyajima, M. Serizawa, R.T. MacGilibray, J.D. Gitlin.
Aceruloplasminemia: molecular characterization of this disorder of iron metabolism.
Proc Natl Acad Sci USA, 92 (1995), pp. 2539-2543
[19.]
I.H. Hung, M. Suzuki, Y. Yamaguchi, D.S. Yuan, R.D. Klausner, J.D. Gitlin.
Biochemical characterization of the Wilson disease protein and functional expression in the yeast Saccharomyces cerevisiae.
J Biol Chem, 272 (1997), pp. 21461-21466
[20.]
G. Loudianos, J.D. Gitlin.
Wilson's disease.
Sem Liver Dis, 20 (2000), pp. 353-364
[21.]
M. Schaefer, H. Roelofsen, H. Wolters, W.J. Hofmann, M. Muller, F. Kuipers, et al.
Location of the Wilson's disease protein in human liver.
Gastroenterology, 117 (1999), pp. 1380-1385
[22.]
M. Schiefermeier, H. Kollegger, C. Madl, C. Polli, W. Oder, H-J Kuhn, et al.
The impact of apolipoprotein E genotypes on age and onset of symptoms and phenotypic expression in Wilson's disease.
Brain, 123 (2000), pp. 585-590
[23.]
J.D. Gitlin.
Aceruloplasminemia. Review.
Pediatr Res, 44 (1998), pp. 271-276
[24.]
N.E. Hellman, M. Schaefer, S. Gerhke, P. Stegen, W.J. Hoffman, J.D. Gitlin, et al.
Hepatic iron overload in aceruloplasminemia.
Gut, 47 (2000), pp. 858-860
[25.]
X-P. Wang.
Wilson disease: asymptomatic or late-onset type.
Acta Neurol Scand, 94 (1996), pp. 421-422
[26.]
G.R. Thomas, J.R. Forbes, E.A. Roberts, J.M. Walshe, D.W. Cox.
Wilson disease gene: spectrum of mutations and their consequences.
Nat Genet, 9 (1995), pp. 210-217
[27.]
I. Sternlieb.
Mitochondrial and fatty changes in hepatocytes of patients with Wilson's disease.
Gastroenteroloy, 55 (1968), pp. 354-367
[28.]
M.L. Schilsky, I. Sternlieb.
Animal models of copper toxicosis.
Advances in veterinary science and comparative medicine, Vol 37, pp. p357-p377
[29.]
D.H. Berman, R.I. Leventhal, J.S. Gavaler, E.M. Cadoff, D.H. Van Thiel.
Clinical differentiation of fulminant Wilsonian hepatitis for other causes of hepatic failure.
Gastroenterology, 100 (1991), pp. 1129-1134
[30.]
J.M. Walshe, M. Yealland.
Chelational treatment of neurological Wilson's disease.
Q J Med, 86 (1993), pp. 197-204
[31.]
S. Starosta-Rubinstein, A.B. Young, K. Kluin, G. Hill, A.M. Aisen, T. Gabrielsen, et al.
Clinical assesment of 31 patients with Wilson'n disease: correlation with structural changes on magnetic resonance imaging.
Arch Neurol, 44 (1987), pp. 365-370
[32.]
H. Mochizuki, K. Kamakura, T. Masaki, M. Okano, T. Nagata, A. Inui, et al.
Atypical MRI features of Wilson's disease: high signal in globus pallidus on T1-weighted images.
Neuroradiology, 39 (1997), pp. 171-174
[33.]
T. Saito, M. Okabe, T. Hosokaba, M. Kurasaki, A. Hata, F. Endo, et al.
Immunohistochemical determination of the Wilson copper-transporting P-type ATPase in the brain tissues of the rat.
Neurosci Lett, 266 (1999), pp. 13-16
[34.]
M.L. Schilsky, I.H. Scheinberg, I. Sternlieb.
Liver transplantation for Wilson's disease: indications and outcome.
Hepatology, 19 (1994), pp. 583-587
[35.]
R.J. Polson, K. Rolles, R.Y. Calne, R. Williams, D. Marsden.
Reversal of severe neurological manifestations of Wilson's disease following orthotopic liver transplantation.
Q M Med, 64 (1987), pp. 685-691
[36.]
J. Willeit, S.G. Kiechl.
Wilson's disease with neurologic impairment but no Kayser-Fleischer rings.
Lancet, 337 (1991), pp. 1426
[37.]
G. Faa, V. Nurchi, L. Demelia, R. Ambu, G. Parodo, T. Congiu, et al.
Uneven hepatic copper distribution in Wilson disease.
J Hepatol, 22 (1995), pp. 303-308
[38.]
P. Steindi, P. Ferenci, H.P. Dienes, G. Grimm, I. Pabinger, C. Madl, et al.
Wilson's disease in patients presenting with liver disease.
Gastroenterology, 113 (1997), pp. 212-218
[39.]
T.D. Lyon, G.S. Fell, D. Gaffney, B.A. McGaw, R.I. Russell, R.H. Park, et al.
Use of a stable copper isotope (Cu65) in the differential diagnosis of Wilson's disease.
Clin Sci, 88 (1995), pp. 727-732
[40.]
S. Hitoshi, M. Iwata, K. Yoshikawa.
Mid-brain pathology of Wilson's disease: MRI analysis of three cases.
J Neurol Neurosurg Psychiatry, 54 (1991), pp. 624-626
[41.]
G.R. Thomas, P.C. Bull, E.A. Roberts, J.M. Walshe, D.W. Cox.
Haplotype studies in Wilson disease.
Am J Hum Genet, 54 (1993), pp. 71-78
[42.]
T. Maier-Dobersberger, C. Mannhalter, S. Rack, G. Granditsch, K. Casere, L. Korninger, et al.
Diagnosis of Wilson's disease in an asymptomatic sibling by DNA linkage analysis.
Gastroenterology, 109 (1995), pp. 2015-2018
[43.]
S.M. Riordan, R. Williams.
The Wilson's disease gene and phenotypic diversity.
J Hepatol, 34 (2001), pp. 165-171
[45.]
S.A. Pfeil, D.J. Lynn.
Wilson's disease. Copper unfettered.
J Clin Gastroenterol, 29 (1999), pp. 22-31
[46.]
G.J. Brewer, C.A. Terry, A.M. Aisen, G.M. Hill.
Worsening of neurological syndrome in patients with Wilson's disease with initial penicillamine therapy.
Arch Neurol, 44 (1987), pp. 490-493
[47.]
I. Shoulson, D. Goldblatt, W. Plassche, G. Wilson.
Some therapeutic observations in Wilson's disease.
Adv Neurol, 37 (1983), pp. 239-246
[48.]
Y. Shiono, S. Wakusawa, H. Hayashi, T. Takikawa, M. Yano, T. Okada, et al.
Iron acumulation in the liver of male patients with Wilson's disease.
Am J Gastroenterol, 96 (2001), pp. 3147-3151
[49.]
I.H. Scheinberg, M.E. Jaffe, I. Sternlieb.
The use of trientine in preventing the effects of interrupting penicillamine therapy in Willson's disease.
N Engl J Med, 31 (1987), pp. 209-213
[50.]
L.A. Anderson, S.L. Hakojarvi, S.K. Boudreaux.
Zinc acetate treatment in Wilson's disease.
Ann Pharmacother, 32 (1998), pp. 78-87
[51.]
G.J. Brewer, R.D. Dick, V. Yuzbasiyan-Gurkan, R. Tankanow, A.B. Young, K.J. Kluin.
Initial therapy of patients with Wilson's disease with tetrathiomolybdate.
Arch Neurol, 48 (1991), pp. 42-47
[52.]
G.J. Brewer, R.D. Dick, V. Jhonson, Y. Wang, V. Yuzbasiyan-Gurkan, K. Kluink, et al.
Treatment of Wilson's disease with ammonium tetrathiomolybdate. I. Initial therapy in neurologically affected patients.
Ach Neurol, 51 (1994), pp. 545-554
[53.]
R.J. Sokol, J.M. McKim, M.W. Devereaux.
Alpha-tocopherol ameliorates oxidant injury in isolated copper-loaded rat hepatocytes.
Pediatr Res, 39 (1996), pp. 259-263
[54.]
J. Díaz, F. Acosta, F. Cañizares, F.S. Bueno, P.L. Tornel, I. Tovar, et al.
Does orthotopic transplantation normalize copper metabolism in patients with Wilson's disease?.
Transplant Proc, 27 (1995), pp. 2306
[55.]
C.L. Chen, Y.S. Chen, C.C. Lui, S.P. Hsu.
Neurologic improvement of Wilson's disease after liver transplantation.
Transplant Proc, 29 (1997), pp. 497-498
[56.]
G. Schumacher, K.P. Platz, A.R. Mueller, R. Neuhaus, T. Steinmuller, W.O. Bechstein, et al.
Liver transplantation: treatment of choice for hepatic and neurological manifestation of Wilson's disease.
Clin Transplant, 11 (1997), pp. 217-224
[57.]
R.T. Bax, A. Hassler, W. Luck, H. Hefter, I. Krageloh-Mann, P. Neuhaus.
Cerebral manifestations of Wilson's disease succesfully treated with liver transplantation.
Neurology, 51 (1998), pp. 863-865
[58.]
A.L. Madsen, W. Marsh, D.H. Alpers.
Intractable neurological Wilson's disease treated with orthotopic liver transplantation.
Dig Dis Sci, 38 (1993), pp. 1746-1750
[59.]
A. Kaushansky, M. Frydman, F. Kaufman, R. Homburg.
Endocrine studies of the ovulatory disturbances in Wilson's disease (hepatolenticular degeneration).
Fertil Steril, 47 (1987), pp. 270-273
[60.]
J.G. Klee.
Undiagnosed Wilson's disease as a cause of unexplained miscariage [letter].
Lancet, 2 (1979), pp. 423
[61.]
I.H. Scheinberg, I. Sternlieb.
Pregnancy in penicillamine-treated patients with Wilson's disease.
N Engl J Med, 293 (1975), pp. 1300-1302
[62.]
I. Sternlieb.
Wilson's disease and pregnancy.
Hepatology, 31 (2000), pp. 531-532
[63.]
J.C. Yarze, P. Martín, S.J. Muñoz, L.S. Friedman.
Wilson's disease: Current status.
Am J Med, 92 (1992), pp. 643-654
[64.]
G.J. Brewer, V.D. Jhonson, R.D. Dick, J.K. Fink, K.J. Kluin.
Treatment of Wilson's disease with zinc. XVII: treatment during pregnancy.
Hepatology, 31 (2000), pp. 364-370
Copyright © 2003. Elsevier España, S.L.. Todos los derechos reservados
